Ipamorelin's human data is limited to two published pharmacokinetic/pharmacodynamic studies: a 1999 PK/PD study (PMID: 10496658) that documented dose-response relationships and peak GH at 30-40 minutes post-injection in human volunteers, and a completed Phase II clinical trial for postoperative ileus (NCT00672074), after which ipamorelin's development for this indication was discontinued without approval
Chui DK, Pugh ND, Walker SM, Gregory L, Shaw RW: Follicular vascularity the predictive value of transvaginal power Doppler ultrasonography in an in-vitro fertilization programme: a preliminary study
Persons receiving other supplement products or any other medication, or those under medical care, should consult a healthcare professional before taking this product
Dose and quality: under-dosing or low-purity grey-market vials change everything
On training days, take 3 g before and after your workout
Package and storage 1.Package: 25kg,, 200kg or 1000 kg in plastic drum